Integrating ERAS and the CMS TEAM Model to Eliminate Surgical Site Infections: A Unified Strategy for Surveillance, Prevention, and Control | Aerobiotix

Integrating ERAS and the CMS TEAM Model to Eliminate Surgical Site Infections: A Unified Strategy for Surveillance, Prevention, and Control

J. Hudson Garrett Jr., Ph.D., MSN, MPH, MBA, IP-BC, PLNC, CFER, AS-BC, VA-BC, CMRP, HACP, HACP-IC, HACP-PE, LTC-CIP, CIC, AL-CIP, CAIP, DICO-C, CPPS, CCHR-S, CPHQ, CVAHP, CPXP, CDIPC, CPHRM, CHIPP-B, FACDONA, FAAPM, eFACHDM, FAPIC, FAOM, FRSPH, FNAP, FAHVAP, FACHE, FSHEA, FIDSA

Surgical Site Infections (SSIs) remain one of the most persistent and costly complications in healthcare, impacting patient outcomes, length of stay, and overall cost of care. As healthcare continues to shift toward value-based models, there is a growing opportunity to align clinical excellence initiatives with reimbursement frameworks.

Two powerful approaches, Enhanced Recovery After Surgery (ERAS) protocols and the CMS Transforming Episode Accountability Model (TEAM), can be strategically integrated to accelerate SSI reduction. When combined with a disciplined focus on surveillance, prevention, and control, this alignment creates a comprehensive pathway to safer surgical care.

The Convergence of ERAS and CMS TEAM

ERAS protocols are evidence-based, multidisciplinary pathways designed to standardize perioperative care, reduce variability, and improve recovery. They emphasize optimization across the surgical continuum, from preoperative preparation to postoperative recovery, targeting factors such as nutrition, glycemic control, antimicrobial prophylaxis, and early mobilization. 

The CMS TEAM Model, on the other hand, represents a new bundled payment approach that holds providers accountable for quality and cost across an entire episode of care. Under CMS TEAM, complications such as SSIs directly impact financial performance, making infection prevention not only a clinical priority but also a strategic imperative. 

Integrating ERAS and CMS TEAM creates a powerful synergy: ERAS provides the clinical framework for best practices, while CMS TEAM reinforces accountability and sustainability through financial incentives. Together, they encourage health systems to adopt standardized, data-driven approaches to reduce complications such as SSIs.

Surveillance: The Foundation of Improvement

Effective SSI reduction begins with robust surveillance. Without accurate, timely data, organizations cannot identify trends, measure performance, or target interventions.

Within an integrated ERAS-CMS TEAM framework, surveillance must be:

  • Comprehensive: Capture data across the entire perioperative episode, including post-discharge infections, which are often underreported.
  • Standardized: Use consistent definitions and methodologies (e.g., CDC NHSN criteria) to ensure comparability.
  • Actionable: Provide real-time or near-real-time insights that enable rapid response.

Advanced environmental monitoring technologies, such as air quality and pathogen burden assessments, further enhance surveillance efforts. For example, understanding airborne contamination levels in the OR can help identify hidden risks contributing to SSIs. When paired with clinical data, these insights enable a more complete picture of infection risk. 

Importantly, surveillance data should be integrated into CMS TEAM reporting structures and ERAS dashboards, ensuring alignment between clinical teams and administrative leadership. This transparency fosters accountability and supports continuous improvement.

Prevention: Standardizing Evidence-Based Practices

Prevention is where ERAS protocols excel. By standardizing best practices across the surgical continuum, ERAS reduces variability, a key driver of SSIs.

Key prevention strategies include:

  • Preoperative Optimization: Screening and managing risk factors such as diabetes, obesity, smoking, and malnutrition. Patient education and prehabilitation programs are critical components.
  • Antimicrobial Stewardship: Ensuring appropriate selection, timing, and dosing of prophylactic antibiotics.
  • Skin Preparation and Asepsis: Adherence to evidence-based skin antisepsis protocols and sterile techniques.
  • Normothermia and Glycemic Control: Maintaining physiological stability during surgery to support immune function.
  • Environmental Controls: Minimizing airborne contamination in the OR through advanced air purification and enhanced point-of-care ventilation strategies.

This is where innovative clinical solutions play a critical role. By actively reducing airborne pathogens in the surgical environment, healthcare organizations can address a significant yet often overlooked source of SSIs. Integrating environmental controls into ERAS pathways strengthens prevention efforts and aligns with CMS TEAM’s focus on reducing complications.

From a CMS TEAM perspective, prevention strategies must also be cost-effective and scalable. ERAS protocols, supported by technologies that enhance environmental safety, provide a high-value approach that improves outcomes while reducing total episode costs.

Control: Sustaining Gains Through Accountability and Adaptation

Control refers to the ability to sustain improvements and respond effectively to emerging risks. This requires a combination of governance, feedback loops, and continuous optimization.

Within the ERAS-CMS TEAM integration, control can be achieved through:

  • Multidisciplinary Governance: Establishing committees that include surgeons, anesthesiologists, infection preventionists, nursing leaders, and administrators to oversee SSI reduction efforts.
  • Performance Feedback: Transport reporting of SSI rates, compliance with ERAS protocols, and environmental metrics to frontline teams.
  • Rapid Cycle Improvement: Using data to identify gaps and implement targeted interventions in real time.
  • Financial Alignment: Leveraging CMS TEAM incentives to reinforce adherence to best practices and investment in preventive technologies.

Control also involves standardizing responses to deviations. For example, if surveillance data indicates an increase in airborne contamination or SSI rates, organizations should have predefined escalation pathways that include environmental interventions, workflow adjustments, and staff re-education.

A Unified Path Forward

The integration of ERAS and the CMS TEAM Model represents a transformative opportunity to reduce SSIs through a coordinated, system-wide approach. By anchoring this integration in the principles of surveillance, prevention, and control, healthcare organizations can move beyond reactive infection management to proactive risk elimination.

Aerobiotix® is uniquely positioned to support this journey by enhancing environmental safety, a critical yet often underutilized component of SSI prevention. When combined with standardized clinical pathways and value-based accountability, these solutions enable organizations to achieve measurable, sustainable improvements.

Ultimately, eliminating SSIs requires more than isolated interventions; it demands alignment across clinical practice, operational strategy, and financial incentives. By bringing ERAS and CMS TEAM together and reinforcing them with robust surveillance, prevention, and control, healthcare systems can deliver safer surgical care, improve patient outcomes, and succeed in the evolving value-based landscape.

Aerobiotix’s Illuvia Sense is uniquely positioned to help healthcare facilities exceed guidelines and reduce risk. This FDA-registered Class II medical device delivers continuous air decontamination and real-time monitoring, ensuring optimal air quality.

About the Author

J. Hudson Garrett Jr., Ph.D., MSN, MPH, MBA, IP-BC, PLNC, CFER, AS-BC, VA-BC, CMRP, HACP, HACP-IC, HACP-PE, LTC-CIP, CIC, AL-CIP, CAIP, DICO-C, CPPS, CCHR-S, CPHQ, CVAHP, CPXP, CDIPC, CPHRM, CHIPP-B, FACDONA, FAAPM, eFACHDM, FAPIC, FAOM, FRSPH, FNAP, FAHVAP, FACHE, FSHEA, FIDSA

Dr. Garrett is an Adjunct Assistant Professor of Medicine in the Division of Infectious Diseases at the University of Louisville School of Medicine. He is Board Certified in Infection Prevention and Control, Advanced Leadership in Infection Control, Patient Safety, Healthcare Risk Management, and Healthcare Management and Leadership. Dr. Garrett is a Liaison to the AORN Guidelines Advisory Board.

 

Dr. Garrett